Work

Tumor pharmacokinetics (PK) and pharmacodynamics (PD) of SAR245409 (XL765) and SAR245408 (XL147) administered as single agents to patients with recurrent glioblastoma (GBM): An Ivy Foundation early-phase clinical trials consortium study.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.2012

Authors: Timothy Francis Cloughesy, Paul S. Mischel, Antonio Marcilio Padula Omuro, Michael Prados, Patrick Y. Wen, Bin Wu, Kevin Rockich, Yi Xu, Joanne J. Lager, Ingo K. Mellinghoff

Institutions: University of California, Los Angeles, Ludwig Cancer Research, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, Dana-Farber Cancer Institute, Sanofi (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2621526835

Cites:

Cited by: 26

Related to: 10